Cargando…
Chemotherapy-induced polyneuropathy in cancer care—the patient perspective
PURPOSE: Chemotherapy-related polyneuropathy (CIPN) is a very common, often dose-limiting side effect that affects the patients’ quality of life. Treatment usually consists of a combination of medicinal, medical, and individualized treatment approaches, although the effectiveness of these therapies...
Autores principales: | Prager, K., Passig, K., Micke, O., Zomorodbakhsch, B., Keinki, C., Hübner, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042917/ https://www.ncbi.nlm.nih.gov/pubmed/36971861 http://dx.doi.org/10.1007/s00520-023-07688-5 |
Ejemplares similares
-
Cancer patients’ perspective on shared decision-making and decision aids in oncology
por: Josfeld, Lena, et al.
Publicado: (2021) -
Internet Information on Oral Cancer Drugs: a Critical Comparison between Website Providers
por: Bartmann, Berit, et al.
Publicado: (2020) -
Chemotherapy-induced polyneuropathy. Part I. Pathophysiology
por: Brzeziński, Krzysztof
Publicado: (2012) -
The Effects of Chemotherapy-Induced Polyneuropathy on Postural Balance
por: Gleeson, Mariah, et al.
Publicado: (2021) -
Take care or “German Angst”? Lessons from cancer care during COVID-19 pandemic in spring 2020
por: Büntzel, Jens, et al.
Publicado: (2021)